303 related articles for article (PubMed ID: 33195698)
1. Cardiac Optogenetics in Atrial Fibrillation: Current Challenges and Future Opportunities.
Floria M; Radu S; Gosav EM; Moraru AC; Serban T; Carauleanu A; Costea CF; Ouatu A; Ciocoiu M; Tanase DM
Biomed Res Int; 2020; 2020():8814092. PubMed ID: 33195698
[TBL] [Abstract][Full Text] [Related]
2. Optoelectronic control of cardiac rhythm: Toward shock-free ambulatory cardioversion of atrial fibrillation.
Portero V; Deng S; Boink GJJ; Zhang GQ; de Vries A; Pijnappels DA
J Intern Med; 2024 Feb; 295(2):126-145. PubMed ID: 37964404
[TBL] [Abstract][Full Text] [Related]
3. Optogenetic termination of atrial fibrillation in mice.
Bruegmann T; Beiert T; Vogt CC; Schrickel JW; Sasse P
Cardiovasc Res; 2018 Apr; 114(5):713-723. PubMed ID: 29293898
[TBL] [Abstract][Full Text] [Related]
4. Light transmittance in human atrial tissue and transthoracic illumination in rats support translatability of optogenetic cardioversion of atrial fibrillation.
Nyns ECA; Portero V; Deng S; Jin T; Harlaar N; Bart CI; van Brakel TJ; Palmen M; Hjortnaes J; Ramkisoensing AA; Zhang GQ; Poelma RH; Ördög B; de Vries AAF; Pijnappels DA
J Intern Med; 2023 Sep; 294(3):347-357. PubMed ID: 37340835
[TBL] [Abstract][Full Text] [Related]
5. The RACE study in perspective of randomized studies on management of persistent atrial fibrillation.
Hagens VE; Van Gelder IC; Crijns HJ;
Card Electrophysiol Rev; 2003 Jun; 7(2):118-21. PubMed ID: 14618033
[TBL] [Abstract][Full Text] [Related]
6. Light-induced termination of spiral wave arrhythmias by optogenetic engineering of atrial cardiomyocytes.
Bingen BO; Engels MC; Schalij MJ; Jangsangthong W; Neshati Z; Feola I; Ypey DL; Askar SF; Panfilov AV; Pijnappels DA; de Vries AA
Cardiovasc Res; 2014 Oct; 104(1):194-205. PubMed ID: 25082848
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological cardioversion of atrial fibrillation: current management and treatment options.
Boriani G; Diemberger I; Biffi M; Martignani C; Branzi A
Drugs; 2004; 64(24):2741-62. PubMed ID: 15563247
[TBL] [Abstract][Full Text] [Related]
8. [Drug and electrical therapy of supraventricular tachyarrhythmias].
Heisel A; Jung J; Schieffer H
Z Kardiol; 2000; 89 Suppl 3():68-74. PubMed ID: 10810788
[TBL] [Abstract][Full Text] [Related]
9. Optogenetic Termination of Cardiac Arrhythmia: Mechanistic Enlightenment and Therapeutic Application?
Sasse P; Funken M; Beiert T; Bruegmann T
Front Physiol; 2019; 10():675. PubMed ID: 31244670
[TBL] [Abstract][Full Text] [Related]
10. [Electrical and pharmacological strategies for early cardioversion of atrial fibrillation].
Linhart M; Lewalter T
Herzschrittmacherther Elektrophysiol; 2006 Jun; 17(2):81-8. PubMed ID: 16786466
[TBL] [Abstract][Full Text] [Related]
11. Hybrid therapy of atrial fibrillation.
Santini M; Pignalberi C; Ricci R; Calò L
Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814
[TBL] [Abstract][Full Text] [Related]
12. Optogenetic termination of atrial tachyarrhythmias by brief pulsed light stimulation.
Nakao M; Watanabe M; Miquerol L; Natsui H; Koizumi T; Kadosaka T; Koya T; Hagiwara H; Kamada R; Temma T; de Vries AAF; Anzai T
J Mol Cell Cardiol; 2023 May; 178():9-21. PubMed ID: 36965700
[TBL] [Abstract][Full Text] [Related]
13. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
Lafuente-Lafuente C; Valembois L; Bergmann JF; Belmin J
Cochrane Database Syst Rev; 2015 Mar; (3):CD005049. PubMed ID: 25820938
[TBL] [Abstract][Full Text] [Related]
14. Contemporary approach to electrical and pharmacological cardioversion of atrial fibrillation.
Rajagopalan B; Curtis AB
Postgrad Med; 2012 Nov; 124(6):26-35. PubMed ID: 23322136
[TBL] [Abstract][Full Text] [Related]
15. Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion.
Opolski G; Stanisławska J; Górecki A; Swiecicka G; Torbicki A; Kraska T
Clin Cardiol; 1997 Apr; 20(4):337-40. PubMed ID: 9098591
[TBL] [Abstract][Full Text] [Related]
16. Oesophageal electrical cardioversion of atrial fibrillation.
Santini L; Forleo GB; Santini M; Romeo F
Minerva Cardioangiol; 2004 Apr; 52(2):73-80. PubMed ID: 15194990
[TBL] [Abstract][Full Text] [Related]
17. Termination of re-entrant atrial tachycardia via optogenetic stimulation with optimized spatial targeting: insights from computational models.
Boyle PM; Murphy MJ; Karathanos TV; Zahid S; Blake RC; Trayanova NA
J Physiol; 2018 Jan; 596(2):181-196. PubMed ID: 29193078
[TBL] [Abstract][Full Text] [Related]
18. [Atrial defibrillator].
Jung W; Lüderitz B
Z Kardiol; 2000; 89 Suppl 3():206-14. PubMed ID: 10810804
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation: what are the effects of drug therapy on the effectiveness and complications of electrical cardioversion?
Sarubbi B; Ducceschi V; D'Andrea A; Liccardo B; Santangelo L; Iacono A
Can J Cardiol; 1998 Oct; 14(10):1267-73. PubMed ID: 9852940
[TBL] [Abstract][Full Text] [Related]
20. Electrical cardioversion for atrial fibrillation and flutter.
Mead GE; Elder AT; Flapan AD; Kelman A
Cochrane Database Syst Rev; 2005 Jul; (3):CD002903. PubMed ID: 16034878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
